The steroid progesterone, an agonist of acrosome reaction, induces a biphasic [Ca 2ϩ ] i -signal in human sperm comprising an initial transient [Ca 2ϩ ] i elevation, and a subsequent ramp or plateau. Nifedipine, an inhibitor of voltage-operated Ca 2ϩ channels, inhibits progesterone-induced acrosome reaction in human sperm, but fluorimetric studies have detected no effect of this compound on the progesterone-induced [Ca 2ϩ ] i signal. We have used single-cell imaging to study the effects of nifedipine on [Ca 2ϩ ] i signalling in human sperm. Analysis of mean responses from large numbers of cells showed that treatment with nifedipine reduced the duration but not the amplitude of the progesterone-induced [Ca 2ϩ ] i transient. In control cells, the latency of the transient peak (maximum fluorescence) fell within the range of 30 -105 s. In the presence of nifedipine, very few cells peaked "late" (Ͼ60 s after application of progesterone). Analysis of transient responses in control cells revealed characteristic "early" and "late" responses, most cells showing both "early" and "late" transients, whereas "late" transients were rare and smaller in the presence of nifedipine. Sustained responses showed strong association with late transients, and occurrence and amplitude of sustained responses were significantly reduced in nifedipine pretreated cells.
Introduction
A pivotal event in induction of the acrosome reaction (AR) by biological agonists is a significant influx of extracellular Ca 2ϩ , resulting in measurable elevation of [Ca 2ϩ ] i Darszon et al., 1999) . However, the mechanisms underlying this Ca 2ϩ -influx are poorly understood. By far the best-characterised mammalian system is induction of AR of mouse spermatozoa by solubilised zona pellucida (ZP), an important inducer of AR in vivo (Wassarman, 1999) . In this system, AR is achieved via activation of (at least) two Ca 2ϩ influx pathways. The first event is the opening of a nonselective cation channel, generating inward current (and consequent depolarisation) which triggers a low-voltage activated, T-type voltage operated calcium channel (VOCC) (Arnoult et al., 1996a (Arnoult et al., ,b, 1999 . The [Ca 2ϩ ] i signal from influx through the T-type VOCC is short-lived (200 ms) but initiates a second, prolonged influx, probably through store-operated Ca 2ϩ channels (O'Toole et al., 2000; Jungnickel et al., 2001) , which activates AR.
Progesterone also acts as an inducer of AR in mammals. This effect is one of the most-studied, and yet least understood, examples of nongenomic steroid action and is potentially highly important in vivo (Bray et al., 1999; Calogero et al., 2000; Kirkman-Brown et al., 2002a) . Many studies have demonstrated the efficacy of micromolar concentrations of progesterone (consistent with levels in the human cumulus; Hartshorne, 1989; Osman et al., 1989) as an inducer of AR in human sperm in vitro. Induction of AR by progesterone in human sperm, as with ZP in the mouse, is mediated by a biphasic influx of Ca 2ϩ . The first phase is a slow transient, with a typical duration of 2-3 min, which is followed by a prolonged plateau or ramp phase (Blackmore et al., 1990; Baldi et al., 1991; Yang et al., 1994; Plant et al., 1995; Aitken et al., 1996; Kirkman-Brown et al., 2000) . Single-cell imaging of the response to progesterone revealed a strong linkage between generation of the transient and sustained responses (Kirkman-Brown et al., 2000) . Further work has shown that the occurrence of the sustained response is strongly dependent upon the amplitude of the preceding [Ca 2ϩ ] i transient, but is resistant to inhibition of tyrosine kinase activity (Kirkman-Brown et al., 2002b ; an J.C.K-B., unpublished observations). There has been little work on progesterone-induced signalling in other mammals but, interestingly, the [Ca 2ϩ ] i response to progesterone in mouse spermatozoa appears to occur as two types of transient response which transpire in different populations of cells (Kobori et al., 2000) . Studies on progesterone-induced AR and generation of diacylglycerol in human sperm have shown that dihydropyridines, selective blockers of VOCCs (primarily the L-type), inhibit the action of progesterone (Shi and Roldan, 1995; O'Toole et al., 1996) , suggesting a vital role for these channels. However, pharmacological studies on the progesterone-induced [Ca 2ϩ ] i response have produced little evidence for involvement of VOCCs. Blockers of L-type VOCCs are reported to be effective only at high (nonspecific) doses (Blackmore et al., 1990; Aitken et al., 1996; Foresta et al., 1993; McLaughlin and Ford, 1994; Morales et al., 2000) . Some fluorimetric studies, which have employed compounds that show some selectivity for T-type VOCCs, have detected effects of these compounds on the amplitude of the [Ca 2ϩ ] i transient. However, the observed effects have varied greatly between studies, with several authors observing no effect (Morales et al., 2000; Blackmore et al., 1999; Garcia et al., 1999; Patrat et al., 2000; Bonaccorsi et al., 2001) . Furthermore, the doses needed have exceeded those normally required for blockade of T-currents (e.g, Enyeart et al., 1993; Randall and Tsien, 1997; Monteil et al., 2000) . The participation of VOCCs in the response to progesterone, let alone the identity of the channel(s) involved, is therefore still an open question.
We have developed a method which permits simultaneous imaging of [Ca 2ϩ ] i in large numbers of individual human sperm, permitting detection and detailed analysis of the [Ca 2ϩ ] i signal that is impossible by fluorimetric or small-sample imaging methods (Kirkman-Brown et al., 2000) . Using this method, we have investigated the effect of the dihydropyridine nifedipine on the progesterone-induced [Ca 2ϩ ] i response in human sperm. We report that the progesterone-induced [Ca 2ϩ ] i transient is composed of discrete early and late components. The late component is selectively inhibited by nifedipine and is important for activation of the sustained [Ca 2ϩ ] i signal. This finding not only provides a significant advance in our understanding of progesterone-induced signalling in sperm, but potentially explains the striking variability in the reported sensitivity of the progesterone-induced [Ca 2ϩ ] i transient to VOCC blockade.
Materials and methods

Preparation, capacitation and confocal imaging of sperm
All donors were recruited at the Birmingham Women's Hospital (Human Fertilisation and Embryology Authority Centre No. 0119), in accordance with the Human Fertilisation and Embryology Authority Code of Practice. Methods of preparation and imaging were as previously described (Kirkman-Brown et al., 2000) . Briefly, semen was collected from healthy donors of proven fertility and a direct swim-up into was performed to select a highly motile population of sperm (1 ml sEBSS 0.3% BSA underlayered with 0.3 ml semen; 37°C, 5% CO 2 ). The top 0.7 ml was removed, pooled, adjusted to 6 million cells/ml and left to capacitate in 200-l aliquots for 6 h, 37°C, 5% CO 2 . For imaging, cells were loaded with Calcium Green 1-AM, introduced into a purpose built chamber, and adhered to poly-lysine-coated coverslips. All agonist and antagonist concentrations are stated at their final concentration. Confocal imaging was performed on a BioRad MRC600, attached to an inverted Nikon Diaphot microscope. A BioRad BHS filter set was employed, using the 488 AR-laser line for excitation.
Confocal data processing and analysis
Data were processed offline by using Lucida software (Kinetic Imaging Ltd., UK). An ovoid was drawn around the head of every spermatozoon, and the average intensity within the head was obtained for all images in the time series. The image series was then studied repeatedly, and if a cell moved such that the defined area no longer contained the entire sperm head, the data from that cell were excluded from analysis. Other criteria for acceptance or rejection of data were as applied and described previously (KirkmanBrown et al., 2000) .
Raw intensity values were imported into Microsoft Excel and normalised by using the following equation:
where R is normalised fluorescence intensity, F is fluorescence intensity at time t, and F rest is the mean of at least 10 determinations of F taken during the control period.
At each time point the normalised fluorescence intensity values (R) for each cell were compiled to generate an overall average normalised head fluorescence (R tot ). The total series of R tot was then plotted to give the population response for that experiment. For each cell, the mean and 95% confidence interval of fluorescent intensity was calculated for: (1) at least 10 images during the control period [C Ϯ c]; (2) the four images spanning the time for the peak of the transient response (as assessed from R tot for that experiment [T Ϯ t]); and (3) 12 images collected during the period from 15 to 18 min after progesterone application (the sustained response [S Ϯ s]). Transient responses were con-
For investigation of the effect of nifedipine on resting [Ca 2ϩ ] i , a similar technique was used, except that for each cell the control intensity [C Ϯ c] was compared with fluorescent intensity for the period 5-10 min after application of the drug [N Ϯ n] . For experiments in which the effects of progesterone were determined after nifedpine treatment, data were normalised by using the post-nifedipine fluorescence [N Ϯ n], and analyses of significant transient and sustained responses were carried out as above.
For investigation of peak latency (delay between progesterone application and the peak of the transient response), the population of cells in which a significant transient occurred (T Ϫ t Ͼ C ϩ c) was further analysed to determine the time (during the first 3 min) at which the peak increase in amplitude occurred. On the basis of this analysis, it became apparent that nifedipine discriminated between responses peaking 15-60 s after progesterone (designated period T1) and 75-120 s after progesterone (designated period T2). To characterise the behaviour of individual cells during the two periods, we then calculated, for each cell, the mean, normalised fluorescence during periods T1 and T2 (T1 Ϯ t1 and T2 Ϯ t2, respectively). Individual cells were then scored for significantly increased fluorescence during period T1 and/or period T2 [compared with control fluorescence for that cell (C Ϯ c)]. Mean fluorescence time plots for each of the categories verified successful sorting of the data.
To compare the occurrence rate of the various components of the progesterone-induced [Ca 2ϩ ] i response in nifedipine-pretreated preparations, mean percentage values were calculated. Tests of significance were carried out by using paired or unpaired, two-tailed t tests (selected according to the data) or chi-square contingency tables. Percentage data was arcsine transformed before testing.
Amplitude distributions for components of the [Ca 2ϩ ] i response were compiled by using the values T, T1, T2, and S (see above). A distribution (% of total population in each amplitude class) was compiled for each experiment, and these were then combined to give mean, normalised values (ϮSEM).
Assessment of progesterone induced acrosome reaction
After capacitation as described (Kirkman-Brown et al., 2000) , 100-l aliquots of sperm were stimulated with either 3.2 M progesterone, 10 M A23187, or solvent (control; 0.05% DMSO). Nifedipine (1, 10, or 50 M) was added to the relevant antagonist treatments 10 min before addition of the agonist. After an incubation of 1 h, slide preparation, staining, and scoring of acrosomal status were undertaken as previously described (Kirkman-Brown et al., 2000 . Tests of difference between treatment groups were carried out by using paired t tests (two tailed) on arcsine transformed percentage AR data in Microsoft Excel.
Materials
Calcium Green-1 AM was from Molecular Probes (Cambridge Bioscience, UK); Pentex fraction V Bovine serum albumin (pH 7) was from Bayer-Pentex (Newbury, Berkshire); supplemented Earle's balanced salt solution (w/o phenol red) was from Gibco BRL (Paisley, Scotland; special order No: 041-94189H); and Fluoromount was from BDH Merck (Poole, Dorset); Nifedipine, Progesterone [4-pregnene-3,20-dione], A23187 ionophore [Free Acid], and all other reagents were analytical or cell-culture grade and were obtained from Sigma (Poole, Dorset).
Results
Effect of nifedipine on acrosome reaction
Consistent with the findings of previous studies (Shi and Roldan, 1995; O'Toole et al., 1996) , we observed a strong inhibition, by nifedipine, of progesterone-induced AR, but no effect on the response to the ionophore A23187. The effect on progesterone-induced AR was most pronounced at a dose of 10 M (Fig. 1 ), so this dose was used for investigation of the [Ca 2ϩ ] i response, except where stated otherwise.
Effect of nifedipine on the population response to progesterone
Upon application of progesterone in control experiments, fluorescent intensity increased in the postacrosomal region of most cells (see below). The mean, normalised fluorescent intensity for all sperm heads in the field of view (R tot ) Fig. 1 . Effects of nifedipine on the progesterone-induced acrosome reaction (AR). Progesterone (3.14 M) significantly increased AR over that in controls and in 0.05% DMSO (SC, solvent vehicle for progesterone) (P Ͻ 0.025; n ϭ 6). This effect was significantly inhibited by pretreatment with nifedipine at all doses used (* indicates P Ͻ 0.01; n ϭ 6, paired t test). A23187 (10 M) increased AR rate to 33%. Nifedipine pretreatment had no effect (N.S.) on A23187-induced or spontaneous AR rate at any of the three doses. All bars show mean Ϯ SEM (n ϭ 6).
increased to a peak within 1-2 min (mean ϭ 28.0 Ϯ 1.8%; n ϭ 23) and then decreased over a similar time course. This transient response was followed by a sustained elevation, which began during, or just after, the falling phase of the transient, and was maintained until the end of the experiment. A similar pattern of response was seen in all experiments for which analysis was carried out, although the amplitude of the sustained response varied considerably (Fig. 2a) . In preparations pretreated with nifedipine (10 M; 5-10 min), the amplitude of the progesterone-induced transient increase in R tot was similar to that in control preparations (mean ϭ 25.1 Ϯ 4.2%; n ϭ 6; NS), but there was a clear change in the duration. In control experiments, the [Ca 2ϩ ] i transient in the R tot trace lasted 3-4 min from onset to completion (Fig. 2a) . In nifedipine-pretreated cells, the transient response peaked slightly earlier and was completed within 2 min (Fig. 2b) . "Half-duration" of the transient increase in R tot (mid point of the rising phase to midpoint of decay) was 1.97 Ϯ 0.10 min (n ϭ 23) for control preparations and 0.95 Ϯ 0.10 min (n ϭ 6) for nifedipine-pretreated preparations. (P Ͻ 0.000025). "Amalgamated" R tot plots, composed by pooling all cells from 6 nifedipine-pretreated preparations (1345 cells) and 20 control preparations (3909 cells) corresponded closely for the initial rise in fluorescence, but in control preparations, a large "shoulder" was present. Plotting of the difference between the two traces revealed a nifedipine-sensitive component that activated after approximately 30 s and was maximal at approximately 2 min (Fig. 2c) .
A second marked effect of nifedipine-pretreatment on R tot traces was that the sustained [Ca 2ϩ ] i response to progesterone was greatly reduced or absent. The mean increase in R tot for the period 15-17 min after application of progesterone (representing the sustained response) was greatly reduced from 14.7 Ϯ 0.8% (n ϭ 19) to 5.6 Ϯ 3.8% (n ϭ 6; P Ͻ 0.025).
Effect of nifedipine on the responses of individual cells to progesterone
In four experiments, recording was started before application of nifedipine. In all of these experiments, a fall in R tot of approximately 5% was observed, which occurred over a period of 1-2 min after exposure to nifedipine (Fig. 2d) . Fluorescent intensity then stabilised or recovered partially before stabilising. Single cell analysis showed that a significant fall in fluorescence occurred in 34.5 Ϯ 4.5% of cells, the amplitude of the effect varying from 10 to 40% (Fig. 2d,  inset) . For analysis of subsequent responses to progesterone, data were normalised by using the stabilised post-nifedipine fluorescence.
Transient responses
Amplitude of transient responses
In control (non-nifedipine pretreated) experiments, the distribution of amplitudes for significant, transient progesterone-induced responses (T, see Materials and methods) formed a slightly negatively skewed bell-shape, with a modal value of 20 -30% increase in fluorescence and a tail of larger responses (Fig. 3a) . The distribution of the amplitudes of transient responses in cells pretreated with nifedipine was similar, though the occurrence of responses in the range 20 -40% was noticeably reduced (Fig. 3a) .
Proportion of cells generating transient responses
In control preparations, the proportion of cells in which a significant transient response (T Ϫ t Ͼ C ϩ c; see Materials and methods) was detected was 77.2 Ϯ 2.5% (n ϭ 23), a value similar to that reported previously (KirkmanBrown et al., 2000) . In experiments on cells pretreated with nifedipine, the frequency of transient responses was 61.7 Ϯ 6.9% of cells (n ϭ 6; P Ͻ 0.025; t test).
Time course and latency of transient responses
R tot traces showed a significant reduction in the duration of the transient response in nifedipine pretreated preparations. Attempts to analyse the distribution of the durations of single cell responses were unsuccessful. The effects of background noise were such that a high proportion of cells were "rejected" by the analysis technique. As an alternative, we examined the effects of nifedipine pretreatment on the latency of the peak response. For each cell in which a significant transient occurred, the time of maximum fluorescence during the 3-min period immediately following application of progesterone was determined. In six nifedipine-pretreated preparations (886 cells), the distribution of latencies had a clear peak at 30 -45 s. Latencies from six control preparations, carried out during the same period as the nifedipine experiments (971 cells), had a much broader distribution of latencies. A peak was still discernible at approximately 45 s, but there was also a large shoulder between 75 and 120 s (Fig. 4) . Cells which peaked Ն75 s after application of progesterone constituted approximately 54% of the population, compared with only 12% in nifedipine-pretreated preparations ( Fig. 4 ; P Ͻ 10 Ϫ61 ).
Types of single cell transient
Analysis of the effects of nifedipine on R tot plots and single cell latencies suggested that nifedipine selectively inhibits a component of the transient [Ca 2ϩ ] i response that peaks Ն75 s after application of progesterone. We further analysed 24 experiments (6 nifedipine and 18 control) by sorting cells according to whether they showed significantly increased fluorescence levels during the early phase (15-60 s; designated T1) and/or the late phase (75-120 s; designated T2) of the transient [Ca 2ϩ ] i response (see Materials and methods, and Fig. 4 for illustration) . Data from a control experiment and a nifedipine-pretreated experiment, carried out on aliquots from the same sample, are illustrated in Fig.  5 . Cells that showed significantly increased fluorescence only during period T1 were detected both in control and nifedipine-pretreated populations and the kinetics of these subpopulations were strikingly similar, fluorescence rising rapidly to peak in 15-30 s and then returning, within a further 60 s to control levels after a brief "undershoot." (Fig.  5a ). Despite the reduced frequency of transient responses in nifedipine-pretreated preparations, the occurrence of cells showing a significant response only during period T1 was increased from 17.5 Ϯ 2.7% (control) to 33.5 Ϯ 3.0% (nifedipine-pretreated; P Ͻ 0.005; nonpaired t test; Fig. 6a ). Cells that showed significantly increased fluorescence only during period T2 were also detected both in control and nifedipine-pretreated populations, and their kinetics were again similar. In these cells, fluorescence often rose only after a 15-to 30-s lag (note point of progesterone addition on Fig. 5b ), reaching peak (typically 10 -30% in control cells) after 75-90 s and then falling slowly (Fig. 5b) . The frequency of occurrence of such cells was reduced after nifedipine pretreatment (10.3% Ϯ 2.6% compared with 15.9 Ϯ 2.1% in controls; Fig. 6a ; NS). Cells in which fluorescence was significantly increased above control levels during both T1 and T2 were present in both sets of data, but the frequency was lower in the nifedipine-pretreated cells (20.0 Ϯ 5.2% compared with 44.5 Ϯ 4.5%; P Ͻ 0.01; nonpaired t test; Fig. 6a) . Strikingly, the shape of the responses in cells which generated a significant increase in fluorescence during both T1 and T2 differed markedly in the two data sets, responses in control cells being broader, with a clear shoulder, which was not present in the nifedipine-treated population (Fig. 5c) .
To compare the amplitudes of the early and late transient responses, we used the values T1 and T2, the mean, normalised fluorescence during periods T1 and T2 respectively (see Materials and methods). The distribution of responses during period T1 was similar in control and nifedipinepretreated cells, but the response during period T2 was clearly different, with both the amplitude and the number of Plot shows the distribution of latencies to peak fluorescence in progesterone-responsive cells. Normalised latency histograms were constructed for each of 6 nifedipine-pretreated preparations (total of 886 cells) and 6 control preparations carried out during the same period (total of 971 cells). Points show mean Ϯ SEM. For control (s, n ϭ 6), and nifedipinepretreated (ᮀ, n ϭ 6) cells. T1 and T2 show the time periods used to sort cells for further analysis. responsive cells being lower in the nifedipine-pretreated preparations (Fig. 6b) .
Sustained responses Amplitude of sustained responses
Significant sustained responses in control preparations took the form of a plateau or a slowly developing ramp (Kirkman-Brown et al., 2000) . The amplitude of single cell responses, assessed 15-18 min after the application of progesterone, was typically a 10 -20% increase in fluorescent intensity over control levels. However, the distribution was strongly negatively skewed with a tail of larger responses with amplitudes extending above 100% (Fig. 3b) . The distribution of sustained responses in cells pretreated with nifedipine also had a modal value of a 10 -20% increase in fluorescence, although the proportion of larger responses was greatly decreased, with very few responses of greater than 70% (Fig. 3b) .
Occurrence of sustained responses and transient response type
The overall frequency of significant, sustained responses was reduced, from 49.9 Ϯ 3.4% of cells in control experiments to 34.1 Ϯ 7.9% in the nifedipine-pretreated preparations (P Ͻ 0.05). Since generation of sustained [Ca 2ϩ ] i responses upon stimulation with progesterone is linked to prior generation of a transient response (Kirkman-Brown et al., 2000) , the occurrence of sustained responses in cells classified into each of the three transient categories (significant increase in fluorescence during T1, T2, or T1 and T2) was investigated. Results from the detailed analysis of 18 control preparations (non-progesterone-pretreated) are summarised in Fig. 6c (left panel) . Sustained responses were most common in cells where fluorescence rose during both periods T1 and T2 (69.0 Ϯ 3.3%), but occurrence in cells responsive during period T2 only was only slightly lower (62.1 Ϯ 4.5%, NS). In cells responsive only during period T1, the occurrence of sustained responses was much lower (32.9 Ϯ 4.4%; P Ͻ 10 Ϫ5 compared with T2 only, paired t) but still significantly greater than that in cells showing no transient response (19.9 Ϯ 3.8%, P Ͻ 0.01; paired t). Analysis of nifedipine-pretreated cells showed a similar pattern of response, though the absolute frequencies were lower ( Fig. 6c; right panel) .
Dose-dependency of the effect of nifedipine
Nifedipine and other dihydropyridine drugs are routinely used as diagnostic tools to identify participation of L-type VOCCs in cellular processes. Since effects of these drugs on L channels are often significant at much lower doses and 10 M is at the top of the useful range for nifedipine (see discussion), we investigated the effect of 1 M nifedipine on the duration of the population transient response. Eight sets of experiments were carried out in which the population response (R tot ) to progesterone was recorded, in aliquots from the same sample, under control conditions and in the presence of both 1 and 10 M nifedipine. Fig. 7a shows results from one such set of experiments. The responses of the nifedipine-pretreated preparations have been normalised to the control response to facilitate comparison. A clear shoulder was detectable in the control R tot trace, which was greatly reduced in the presence of 10 M nifedipine. Nifedipine (1 M) also reduced transient duration, but to a lesser extent. This effect of 1 M nifedipine was discernible in six of the eight sets of experiments but was less marked than the effect of 10 M nifedipine. The mean response to progesterone, under each of the three conditions, was calculated after first normalising the traces to the amplitude at 30 s after application of progesterone (peak amplitude before activation of the nifedipine-sensitive component; see Fig. 2c ). The rate of decay of the transient response was clearly greater at both concentrations of nifedipine, the effect being more marked at 10 M (Fig. 7b) . To compare the potency of nifedipine at 1 and 10 M, the nifedipinesensitive component was obtained (by subtraction of traces) for each experiment. The kinetics of the nifedipine-sensitive component were strikingly similar at the two doses, but the mean amplitude was approximately twice as large with 10 M nifedipine.
Discussion
We have shown previously that progesterone induces a biphasic [Ca 2ϩ ] i response in human sperm (KirkmanBrown et al., 2000) . The sustained component of the response occurs primarily, but not exclusively, in those cells demonstrating a transient. We have now shown that pretreatment of cells with 1-10 M nifedipine, which causes blockade of progesterone-induced AR, modifies the [Ca 2ϩ ] i response and reveals the existence of two components within the initial [Ca 2ϩ ] i transient. The late component is strongly linked to generation of the sustained response. 
Effect of nifedipine on the progesterone-induced [Ca 2ϩ ] i transient
Pretreatment of cells with 10 M nifedipine (5-10 min) had no significant effect on the amplitude of the population transient (R tot ), but markedly reduced its duration. Single cell analysis showed that this was due to a reduction in the proportion of single cell responses that peaked relatively late (Ն75 s) after progesterone challenge. Sorting of cells according to whether the fluorescence was elevated significantly during the early (15-60 s) and/or late (75-120 s) parts of the [Ca 2ϩ ] i transient revealed two types of response that were strikingly different. The early responses were brief (completion within 60 -90 s followed by an undershoot; Fig.  5a ) and nifedipine-resistant, whereas the late responses activated after a longer latency (15-30 s) decayed more slowly and were both smaller and less common in nifedipinepretreated preparations (Figs. 5 and 6) . The kinetics of late responses resemble those of the nifedipine-sensitive component of R tot (compare Figs. 2c and 5b) . We conclude that the progesterone-induced [Ca 2ϩ ] i transient includes two components, one of which is inhibited by 10 M nifedipine (transient 2) and the other is not (transient 1). Interestingly, the occurrence of two types of progesterone-induced [Ca 2ϩ ] i responses with different durations (60 -80 s and Ͼ180 s) has been reported in mouse sperm. The longer lasting type of response, which required high doses of progesterone for induction (Ͻ30% of cells were responsive at 40 M) was sensitive to the VOCC blocker pimozide at 1 M (Kobori et al., 2000) .
Effect of nifedipine on the progesterone-induced sustained [Ca 2ϩ ] i response
Besides modifying the transient response, 10 M nifedipine had a marked effect on the sustained [Ca 2ϩ ] i signal. We have previously shown that occurrence of the sustained response in an individual cell is closely linked to the occurrence and amplitude of the transient response (KirkmanBrown et al., 2000) . It might, therefore, be anticipated that the nifedipine-induced reduction in the frequency of occurrence of transient responses [T; scored irrespective of the contributing component(s)] would be accompanied by an equivalent effect on the frequency of occurrence of sustained responses. In fact, the nifedipine-induced reduction in the frequency of occurrence of sustained responses (Ͼ30%) was proportionately greater than the effect on transient responses (Ͻ20%). Furthermore, though the modal amplitude of sustained responses was unchanged (10 -20%), nifedipine-pretreatment prevented the occurrence of the large (Ͼ70%) sustained responses seen in a proportion of control cells (Fig. 3b) . Both of these observations are consistent with a reduction of mean amplitude in nifedipine-treated cells, coupled with an inability to detect very small (Ͻ10%) responses that may not significantly exceed the noise. The data summarised in Fig. 6c suggest that selective inhibition of transient 2 by nifedipine is of particular importance in this respect, transient 2 being significantly more effective as an "inducer" of the sustained response than transient 1. It is therefore possible that blockade of the nifedipine-sensitive channels that underlie transient 2 is responsible for the strong inhibition of sustained [Ca 2ϩ ] i responses that occur in nifedipine-treated preparations. An alternative explanation is that the sustained [Ca 2ϩ ] i response, as well as transient 2, is carried by a nifedipine-sensitive channel. If the action of nifedipine is through blockade of VOCCs (see below), then this is unlikely since these channels (including L-type channels; which seem to be present in mature sperm; Kirkman-Brown et al., 2002a; Benoff, 1998) normally inactivate within a few seconds. However, it is worthy of note that: (1) after sorting cells according to the nature of the transient response, nifedipine reduced the proportion of cells generating sustained responses in all categories, and (2) treatment of hamster sperm with 10 M nifedipine was observed to inhibit selectively the prolonged component of the ZPinduced [Ca 2ϩ ] i response (Shirakawa and Miyazaki, 1999) . A direct effect of nifedipine on channels participating in the progesterone-induced sustained influx therefore remains a possibility.
The nifedipine-sensitive component of the transient
Progesterone causes depolarisation of the human sperm membrane potential (Foresta et al., 1993; Patrat et al., 2002) . It thus appears that the dihydropyridine-sensitive component of progesterone-induced Ca 2ϩ influx is not identical to the influx induced by K ϩ -mediated depolarisation. One interpretation is that the effect of nifedipine on progesterone-induced Ca 2ϩ influx does not involve VOCCs. Though this remains a possibility, we consider it more likely that progesterone activates a specific population of nifedipine-sensitive VOCCs through a combination of depolarisation and another agonist-induced process. Such a bifurcating pathway has been proposed for activation of VOCCs in mouse spermatozoa by zona pellucida (Arnoult et al., 1996a; Darszon et al., 1999) .
Doses of 1-10 M nifedipine (as employed here) are commonly used to assess the involvement of L-type VOCCs in cellular activities (Cohen, 2001; Godukhin et al., 2002; Piacentino et al., 2002; Kawanabe et al., 2002; Park et al., 2002; Waitkus-Edwards et al., 2002; Nakano et al., 2002; Hashitani et al., 2002; Staras et al., 2002) . In human spermatozoa, 1 M nifedipine was approximately half as effective as 10 M in blocking the progesterone-induced AR (Fig. 1) and was half as effective in inhibiting the progesterone-induced late transient (Fig. 7) . Since the relationship between Calcium Green 1 fluorescence and [Ca 2ϩ ] is nonlinear, the effect of 1 M nifedipine on Ca 2ϩ influx is, in fact, considerably more than half as great as that at 10 M. If 10 M is a saturating or near-saturating dose, then the IC 50 for the effect of nifedipine is probably in the near-M or low-M range. In comparison, blockade of contractile activity in heart and vascular tissues occurs at nM concentrations (Sun and Triggle, 1995) . However, sensitivity to blockade by dihydropyridines of L channels (or L-channeldependent biological responses) can vary widely, even among cardiac and vascular tissues (Sun and Triggle 1995; Sarsero et al., 1998) . This phenomenon reflects, at least in part, the expression of differentially spliced isoforms in area IS6 of the ␣ 1 subunit (Welling et al., 1997) , an effect that has recently been demonstrated in recombinant ␣ 1C subunits (Morel et al., 1998) . IS6 is one of the regions at which human testis ␣ 1C shows alternative splicing (Goodwin et al., 1999) . ␣ 1D mRNA (L-type) has been detected in mouse (Lievano et al., 1996) and human (E.L. Punt, unpublished observations). testis, and ␣ 1D subunits have recently been reported in mouse round spermatids (Son et al., 2002) , but some researchers have failed to detect ␣ 1D in spermatozoa (Jagannathan et al., 2002b) . Doses of 1-10 M are required for blockade of recombinant ␣ 1D channels (Bell et al., 2001) . In addition to the effects of alternative splicing, the efficacy of L channel blockade by dihydropyridines is strongly voltage-dependent, the drugs being more effective at depolarised membrane potentials (Sanguinetti and Kass, 1984) . It is believed that the sperm membrane hyperpolarises during capacitation to release T-type VOCCs from inactivation (Arnoult et al., 1999) . We conclude that the efficacy of nifedipine in inhibiting the response to progesterone is not inconsistent with action on an L-type VOCC.
Another possibility is that nifedipine exerts its effect through blockade of T-type channels. In previous studies, compounds that are recognised blockers of T-channels (e.g., pimozide and mibefradil) have been reported by some authors to affect the progesterone-induced [Ca 2ϩ ] i response in human spermatozoa (e.g., Morales et al., 2000; Garcia et al., 1999; Patrat et al., 2000) . Interpretation of these data is difficult since these drugs can have effects on high voltageactivated channels at the doses at which they are normally used (Gould et al., 1983; Enyeart et al., 1990; Bezprozvanny and Tsien, 1995; Ito et al., 1996; Protas and Robinson, 2000; Wu et al., 2000) . Conversely, though dihydropyridines such as nifedipine are selective for VOCCs and particularly effective as blockers of L-type channels, these compounds do not discriminate absolutely between L and T-type currents. Though some T-currents show little blockade by 10 M nifedipine (e.g., Gu et al., 1999; Lacinova et al., 2000) , the low voltage-activated current of mouse spermatocytes is extremely sensitive with an IC 50 close to 1 M (Santi et al., 1996; Arnoult et al., 1998), similar to that estimated for nifedipine in this study. On balance, though the pharmacological data permit no firm conclusion, we consider the kinetics of the nifedipine-sensitive component (transient 2) are such that, if the effect of nifedipine reflects inhibition of a VOCC, it is more likely that it is exerted on an L-type than a T-type channel. Detailed interpretation of the effects of VOCC-blocking drugs on [Ca 2ϩ ] i signalling in human sperm may ultimately require parallel dose-effect studies on the actions of these compounds on [Ca 2ϩ ] i signals in spermatozoa and channels in patch clamped cells. As T-type channel currents, which have been characterised in mouse spermatogenic cells can be detected only rarely in immature human male germ cells (and no other VOCC currents were detected) patch clamping of mature spermatozoa or the use of expressed recombinant channels may be required (Jagannathan et al., 2002a,b) .
In summary, we describe here, for the first time, the occurrence of two, discrete components of the progesteroneinduced [Ca 2ϩ ] i signal in human spermatozoa, recognisable at the level of individual cells. The later of these (transient 2) is sensitive to the dihydropyridine nifedipine (1-10 M) and is apparently the more important in activation of the sustained [Ca 2ϩ ] i signal and acrosome reaction. These data at last explain the efficacy of dihydropyrinies as inhibitors of AR and their apparent contraceptive effect (Hershlag et al., 1995) . A crucial next step is characterisation of the early transient (transient 1) in dihydropyridine-treated cells in which it is pharmacologically isolated.
